5E Advanced Materials, Inc. — Form 10-Q Summary
Period clarification: The supplied filing is for the quarter ended March 31, 2024 (the third quarter of fiscal 2024), not 2022 Q3. It was signed April 29, 2024. Amounts below are in U.S. dollars; financial statement amounts are in thousands unless noted.
Business context and reporting period
5E is developing its Fort Cady boron and lithium project in California and had not generated revenue from operations. The filing covers the three and nine months ended March 31, 2024, with comparisons to the same periods in 2023.
Financial performance and liquidity
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Revenue | None reported | None reported |
| Operating expenses | $4.2 million, versus $8.3 million | $20.8 million, versus $28.0 million |
| Loss from operations | $4.2 million, versus $8.3 million | $20.8 million, versus $28.0 million |
| Net loss | $25.9 million, versus $10.1 million | $45.9 million, versus $20.4 million |
| Basic and diluted loss per share | $0.44, versus $0.23 | $0.94, versus $0.47 |
| Operating cash used | $19.6 million for nine months, versus $24.1 million | |
| Investing cash used | $5.9 million for nine months, versus $30.0 million | |
| Financing cash provided | $13.2 million for nine months, versus $59.3 million |
The quarter and year-to-date net losses included a $21.0 million non-cash loss on extinguishment of debt related to the January 2024 note restructuring. The prior-year nine-month period included an $11.7 million derivative gain. No income tax expense or benefit was recorded. Gross interest expense was partly capitalized to construction in progress; reported net interest expense was $0.8 million for the quarter and $4.3 million for nine months.
- Cash and cash equivalents were $8.0 million at March 31, 2024, down from $20.3 million at June 30, 2023. Working capital was $2.7 million, down from $13.3 million.
- Long-term debt, net, was $63.3 million; convertible-note principal was $65.7 million. Notes mature August 15, 2028, carry 4.5% interest if paid in cash or 10% if paid in additional notes, and are convertible into common stock.
- Construction in progress was $75.7 million, versus $67.6 million at June 30, 2023. Purchase-order commitments were $4.7 million.
- January equity placements generated $15.8 million net and issued 19.0 million shares. Shares outstanding increased from 44.2 million at June 30, 2023 to 63.3 million at March 31, 2024.
Material changes versus the prior comparable period
- Operating expenses fell 49% in the quarter and 26% for nine months, primarily reflecting lower project costs and, in the quarter, lower general and administrative expenses. Project expense reductions for nine months mainly reflected lower plug-and-abandonment activity.
- Despite lower operating expenses, net loss increased because of the $21.0 million debt-extinguishment charge; year-to-date results also lacked the prior-year derivative gain.
- Cash used for investing fell 80% year over year as construction spending slowed. Cash used in operations declined 19%.
- The January restructuring extended note maturity to 2028 and changed interest and conversion terms, but did not provide incremental capital through the debt amendment itself. The related equity placements provided cash and substantially increased shares outstanding.
Outlook, commentary, risks, and unusual items
- Management reported that well-field injection began January 1, 2024. More than 50,000 gallons of pregnant leach solution were accumulated in the first three months of mining operations, with an average head grade of 5.5%. A Louisiana laboratory produced commercial-grade boric acid, confirmed by an independent analysis.
- The Small-Scale Facility began production in April 2024, after the reporting date. Management expects initial capacity of up to 2,000 short tons of boric acid annually, with potential to scale to a 9,000-short-ton run rate and increase lithium production. Customer qualification remains to be completed.
- The target for initial commercial production was shifted from fiscal 2026 to the second half of calendar 2026 or first half of calendar 2027. The timeline depends on funding, construction, permits, and other factors. Fluor was selected to lead FEL-2 engineering work.
- Management and the financial statements state that substantial doubt exists about the Company’s ability to continue as a going concern. Management expects to need additional financing within 12 months. If cash falls below the $7.5 million minimum covenant after December 31, 2024, an uncured default could make the notes immediately due; the Company says it could not repay them without additional financing.
- On April 28, 2024, noteholders extended the minimum-cash covenant waiver through December 31, 2024. The $7.5 million minimum applies thereafter. The Company also has a $15 million equity distribution program, but had made no sales under it through March 31, 2024.
- A former construction contractor counterclaimed for approximately $5.5 million. The Company disputes the claim, and it could not estimate reasonably possible losses. The filing also identifies permitting, project execution, commodity-price, financing, and dilution risks.
Most important facts for investors to verify
- Available cash, spending rate, and whether the Company secures financing sufficient to sustain operations and meet the minimum-cash covenant.
- Small-Scale Facility production performance, product quality, customer qualification, and the timing and costs of larger-scale development.
- Updated commercial-production schedule, required permitting—including EPA approval—and project funding needs.
- Convertible-note terms, accrued interest, potential conversion dilution, and any further covenant amendments or defaults.
- Progress and potential exposure in the contractor litigation, alongside the $4.7 million purchase commitments.